Insider Trading Alert - BWA, BIIB And INVN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 19, 2014, 110 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $21.54 to $422,568,000.00.

Highlighted Stocks Traded by Insiders:

BorgWarner (BWA) - FREE Research Report

Lissalde Frederic who is Vice President at BorgWarner sold 5,200 shares at $58.21 on Feb. 19, 2014. Following this transaction, the Vice President owned 33,353 shares meaning that the stake was reduced by 13.49% with the 5,200-share transaction.

The shares most recently traded at $59.77, up $1.56, or 2.6% since the insider transaction. Historical insider transactions for BorgWarner go as follows:

  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 20,000

The average volume for BorgWarner has been 1.4 million shares per day over the past 30 days. BorgWarner has a market cap of $13.2 billion and is part of the consumer goods sector and automotive industry. Shares are up 6.01% year-to-date as of the close of trading on Wednesday.

BorgWarner Inc. manufactures and sells engineered automotive systems and components primarily for powertrain applications worldwide. The stock currently has a dividend yield of 0.86%. The company has a P/E ratio of 21.5. Currently there are 9 analysts that rate BorgWarner a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BWA - FREE

TheStreet Quant Ratings rates BorgWarner as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full BorgWarner Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Biogen Idec (BIIB) - FREE Research Report

Holtzman Steven H who is EVP Corporate Development at Biogen Idec sold 1,222 shares at $327.90 on Feb. 19, 2014. Following this transaction, the EVP Corporate Development owned 9,412 shares meaning that the stake was reduced by 11.49% with the 1,222-share transaction.

The shares most recently traded at $329.22, up $1.32, or 0.4% since the insider transaction. Historical insider transactions for Biogen Idec go as follows:

  • 4-Week # shares sold: 6,196
  • 12-Week # shares sold: 23,655
  • 24-Week # shares sold: 33,974

The average volume for Biogen Idec has been 1.4 million shares per day over the past 30 days. Biogen Idec has a market cap of $79.2 billion and is part of the health care sector and drugs industry. Shares are up 19.82% year-to-date as of the close of trading on Wednesday.

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. The company has a P/E ratio of 42.9. Currently there are 14 analysts that rate Biogen Idec a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BIIB - FREE

TheStreet Quant Ratings rates Biogen Idec as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Biogen Idec Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

InvenSense (INVN) - FREE Research Report

Artiman Ventures L P who is 10% Owner at InvenSense sold 578,500 shares at $20.81 on Feb. 19, 2014. Following this transaction, the 10% Owner owned 110,961 shares meaning that the stake was reduced by 83.91% with the 578,500-share transaction.

The shares most recently traded at $20.22, down $0.59, or 2.94% since the insider transaction. Historical insider transactions for InvenSense go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 15,000
  • 24-Week # shares sold: 59,950

The average volume for InvenSense has been 2.5 million shares per day over the past 30 days. InvenSense has a market cap of $1.8 billion and is part of the technology sector and electronics industry. Shares are up 0.19% year-to-date as of the close of trading on Wednesday.

InvenSense, Inc. designs, develops, markets, and sells micro-electro-mechanical system (MEMS) gyroscopes for motion tracking devices in consumer electronics. The company has a P/E ratio of 74.4. Currently there are 6 analysts that rate InvenSense a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on INVN - FREE

TheStreet Quant Ratings rates InvenSense as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and premium valuation. Get the full InvenSense Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Daimler Slumps After Profit Warning Cites 'Import Tariffs' in US-China Trade War

Daimler Slumps After Profit Warning Cites 'Import Tariffs' in US-China Trade War

Oil Prices Slide as Saudi Energy Minister Suggests OPEC Output Deal Imminent

Oil Prices Slide as Saudi Energy Minister Suggests OPEC Output Deal Imminent

Global Stocks Mixed, Dollar Firm as Trade Tensions Keep Investors Cautious

Global Stocks Mixed, Dollar Firm as Trade Tensions Keep Investors Cautious

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record